Citation

Zhang L, Gao SH, Zhou CF, Lin RC, Liu CH. Zhongguo Zhong Yao Za Zhi 2006; 31(23): 2010-2013.

Affiliation

Center or Drug reevaluation, State Food and Drug Administration, Beijing 100061, China.

Copyright

(Copyright © 2006, Zhongguo Zhong yi yan jiu yuan Zhong yao yan jiu suo)

DOI

unavailable

PMID

17348199

Abstract

By comprehensively reviewing the origin and history of Niuhuang Jiedu Wan and its "derivatives", we studied the clinical records of realgar, investigated its clinical usage, dosage, efficacy, and toxicity in the literatures. We pinpointed the factors that might be associated with safety problems of Niuhuang Jiedu Pian (Wan) and other traditional Chinese medicine (TCM) preparations containing arsenic substances. In this article we also put forward suggestions for strengthening the surveillance and administration of similar TCM preparations.

Language: zh